IL-2 Regulates CD103 Expression on CD4+ T Cells in Scurfy Mice that Display Both CD103-Dependent and Independent Inflammation

Scurfy (Sf) mice lack CD4(+)Foxp3(+) regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4(+) T cells. Introducing Il2(-/-) gene into Sf mice (Sf.Il2(-/-)) inhibited inflammation in skin and lung. As a major integrin receptor for the organs, we compared CD103 expression...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 183; no. 2; pp. 1065 - 1073
Main Authors Sharma, Rahul, Sung, Sun-sang Joe, Abaya, Christian E, Ju, Angela Chiao-Ying, Fu, Shu Man, Ju, Shyr-Te
Format Journal Article
LanguageEnglish
Published United States Am Assoc Immnol 15.07.2009
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Scurfy (Sf) mice lack CD4(+)Foxp3(+) regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4(+) T cells. Introducing Il2(-/-) gene into Sf mice (Sf.Il2(-/-)) inhibited inflammation in skin and lung. As a major integrin receptor for the organs, we compared CD103 expression on the CD4(+) T cells of B6, Il2(-/-), Sf, and Sf.Il2(-/-) mice. CD103(+)CD4(+) T cells, but not CD8(+) T cells or CD11c(+) dendritic cells, were significantly up-regulated only in Sf mice, indicating Il2(-/-) dominantly and specifically inhibited CD103 up-regulation in Sf CD4(+) T cells. In addition, CD4(+)Foxp3(+) regulatory T cell CD103 expression was not reduced in Il2(-/-) mice. Introducing CD103(-/-) into Sf mice inhibited inflammation in skin and lung as compared with age-matched Sf mice, but they died at approximately 7 wk old with inflammation developed in skin, lungs, and colon, demonstrating fatal MOI induced by CD103-independent mechanism. Transfer of Sf CD4(+) T cells induced MOI more rapidly than CD103(-)CD4(+) T cells, indicating the presence of CD103-dependent mechanism for inflammation. In vitro stimulation with anti-CD3 plus anti-CD28 beads confirmed that CD103 induction in the CD4(+)Foxp3(-) T cells in Il2(-/-) and Sf.Il2(-/-) is defective and cannot be restored by rIL-2 or rIL-15. The data indicate that IL-2 is required for optimal CD103 induction on CD4(+) T cells in Sf mice and this effect contributes to inflammation in an organ-specific manner. IL-2 also has additional roles because the protection of skin and lung inflammation in Sf.Il2(-/-), but not Sf.CD103(-/-) mice is lifelong and Sf.Il2(-/-) mice have longer lifespan than Sf.CD103(-/-) mice.
AbstractList Scurfy (Sf) mice lack CD4(+)Foxp3(+) regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4(+) T cells. Introducing Il2(-/-) gene into Sf mice (Sf.Il2(-/-)) inhibited inflammation in skin and lung. As a major integrin receptor for the organs, we compared CD103 expression on the CD4(+) T cells of B6, Il2(-/-), Sf, and Sf.Il2(-/-) mice. CD103(+)CD4(+) T cells, but not CD8(+) T cells or CD11c(+) dendritic cells, were significantly up-regulated only in Sf mice, indicating Il2(-/-) dominantly and specifically inhibited CD103 up-regulation in Sf CD4(+) T cells. In addition, CD4(+)Foxp3(+) regulatory T cell CD103 expression was not reduced in Il2(-/-) mice. Introducing CD103(-/-) into Sf mice inhibited inflammation in skin and lung as compared with age-matched Sf mice, but they died at approximately 7 wk old with inflammation developed in skin, lungs, and colon, demonstrating fatal MOI induced by CD103-independent mechanism. Transfer of Sf CD4(+) T cells induced MOI more rapidly than CD103(-)CD4(+) T cells, indicating the presence of CD103-dependent mechanism for inflammation. In vitro stimulation with anti-CD3 plus anti-CD28 beads confirmed that CD103 induction in the CD4(+)Foxp3(-) T cells in Il2(-/-) and Sf.Il2(-/-) is defective and cannot be restored by rIL-2 or rIL-15. The data indicate that IL-2 is required for optimal CD103 induction on CD4(+) T cells in Sf mice and this effect contributes to inflammation in an organ-specific manner. IL-2 also has additional roles because the protection of skin and lung inflammation in Sf.Il2(-/-), but not Sf.CD103(-/-) mice is lifelong and Sf.Il2(-/-) mice have longer lifespan than Sf.CD103(-/-) mice.
Abstract Scurfy (Sf) mice lack CD4+Foxp3+ regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4+ T cells. Introducing Il2−/− gene into Sf mice (Sf.Il2−/−) inhibited inflammation in skin and lung. As a major integrin receptor for the organs, we compared CD103 expression on the CD4+ T cells of B6, Il2−/−, Sf, and Sf.Il2−/− mice. CD103+CD4+ T cells, but not CD8+ T cells or CD11c+ dendritic cells, were significantly up-regulated only in Sf mice, indicating Il2−/− dominantly and specifically inhibited CD103 up-regulation in Sf CD4+ T cells. In addition, CD4+Foxp3+ regulatory T cell CD103 expression was not reduced in Il2−/− mice. Introducing CD103−/− into Sf mice inhibited inflammation in skin and lung as compared with age-matched Sf mice, but they died at ∼7 wk old with inflammation developed in skin, lungs, and colon, demonstrating fatal MOI induced by CD103-independent mechanism. Transfer of Sf CD4+ T cells induced MOI more rapidly than CD103−CD4+ T cells, indicating the presence of CD103-dependent mechanism for inflammation. In vitro stimulation with anti-CD3 plus anti-CD28 beads confirmed that CD103 induction in the CD4+Foxp3− T cells in Il2−/− and Sf.Il2−/− is defective and cannot be restored by rIL-2 or rIL-15. The data indicate that IL-2 is required for optimal CD103 induction on CD4+ T cells in Sf mice and this effect contributes to inflammation in an organ-specific manner. IL-2 also has additional roles because the protection of skin and lung inflammation in Sf.Il2−/−, but not Sf.CD103−/− mice is lifelong and Sf.Il2−/− mice have longer lifespan than Sf.CD103−/− mice.
Author Fu, Shu Man
Abaya, Christian E
Sharma, Rahul
Sung, Sun-sang Joe
Ju, Shyr-Te
Ju, Angela Chiao-Ying
Author_xml – sequence: 1
  fullname: Sharma, Rahul
– sequence: 2
  fullname: Sung, Sun-sang Joe
– sequence: 3
  fullname: Abaya, Christian E
– sequence: 4
  fullname: Ju, Angela Chiao-Ying
– sequence: 5
  fullname: Fu, Shu Man
– sequence: 6
  fullname: Ju, Shyr-Te
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19553521$$D View this record in MEDLINE/PubMed
BookMark eNpFkE1v1DAQhi1URLeFOyfkExxQyjj-So40W2ClRUhQzpY3nnRdOU6IEy174L9jtFshjTQz0jOPNO8VuYhDREJeM7gRIOoPj77vlziEG6hAcCmekRWTEgqlQF2QFUBZFkwrfUmuUnoEAAWleEEuWS0llyVbkT-bbVHS7_iwBDtjos2aAad3v8cJU_JDpLmatXhP72mDISTqI_3RLlN3pF99i3Te25mufRqDPdLbYd6fDMUaR4wO40xtdHSTx6d9E7tg-97O2f6SPO9sSPjq3K_Jz093982XYvvt86b5uC1artlciEpAZTVH19VcgkNdlQ7qutayQ1dprKwtoXbcVcJpBzunADlHvUOnMsOvyduTd5yGXwum2fQ-tfkfG3FYklFaSK25zCCcwHYaUpqwM-PkezsdDQPzL3LzFLk5R55P3pzdy65H9__gnHEG3p2AvX_YH_yEJvU2hIwzczgcWMVNmfVK8r9_nIw8
CitedBy_id crossref_primary_10_1016_j_clim_2010_04_004
crossref_primary_10_1016_j_jaci_2014_03_010
crossref_primary_10_1016_j_jaut_2019_05_005
crossref_primary_10_4049_jimmunol_1002677
crossref_primary_10_1002_eji_201142114
crossref_primary_10_1002_eji_201142242
crossref_primary_10_1016_j_jaut_2011_01_001
crossref_primary_10_4049_jimmunol_0904100
crossref_primary_10_1016_j_jaci_2015_12_1314
crossref_primary_10_1152_ajprenal_00236_2017
crossref_primary_10_1002_ptr_8222
crossref_primary_10_4049_jimmunol_0804355
crossref_primary_10_1002_iid3_435
crossref_primary_10_1016_j_jaut_2012_02_001
crossref_primary_10_1002_art_37800
crossref_primary_10_1007_s00018_021_03877_9
crossref_primary_10_1089_jir_2011_0049
crossref_primary_10_3390_biology1010018
crossref_primary_10_1016_j_jneuroim_2010_01_001
crossref_primary_10_1111_sji_12009
Cites_doi 10.4049/jimmunol.168.7.3188
10.1038/ni1526
10.1038/83707
10.1126/science.1079490
10.1002/eji.1830201008
10.4049/jimmunol.174.9.5444
10.1136/jcp.48.2.143
10.4049/jimmunol.176.9.5255
10.4049/jimmunol.175.3.1694
10.1016/j.smim.2003.12.003
10.1016/S0091-6749(97)70175-1
10.1073/pnas.89.5.1924
10.1084/jem.20041982
10.1084/jem.20031803
10.1083/jcb.140.1.197
10.1016/S1074-7613(00)80566-X
10.1038/372190a0
10.1084/jem.20051100
10.1002/eji.1830250333
10.1093/intimm/dxl044
10.1006/cimm.1998.1282
10.4049/jimmunol.179.12.8035
10.1084/jem.194.10.1541
10.4049/jimmunol.175.3.1965
10.1016/0092-8674(93)80067-O
10.1136/jmg.39.8.537
10.4049/jimmunol.172.10.5967
10.1002/eji.1830240322
10.1038/ni909
10.1038/ni904
10.1038/83784
10.1016/0165-2478(88)90056-9
10.1046/j.1365-2567.2001.01232.x
10.1073/pnas.192162899
10.1016/j.jaut.2007.04.001
10.1038/nature07336
10.1084/jem.20040662
10.1016/S1074-7613(00)00080-7
10.1002/eji.1830170910
10.1073/pnas.0507014102
10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R
10.1074/jbc.M308707200
10.4049/jimmunol.163.9.5086
10.1016/j.coi.2005.09.002
10.1084/jem.189.10.1631
10.1002/eji.1830241138
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.4049/jimmunol.0804354
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 1073
ExternalDocumentID 10_4049_jimmunol_0804354
19553521
www183_2_1065
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R21 AI079906
– fundername: NIAMS NIH HHS
  grantid: R01 AR049449
– fundername: NIAID NIH HHS
  grantid: AI-079906
– fundername: NIDCR NIH HHS
  grantid: R01 DE017570
– fundername: NIAMS NIH HHS
  grantid: AR-049449
– fundername: NIAMS NIH HHS
  grantid: R01 AR047988
– fundername: NIAMS NIH HHS
  grantid: AR-047988
– fundername: NIAMS NIH HHS
  grantid: AR-051203
– fundername: NIAMS NIH HHS
  grantid: R01 AR051203-04
– fundername: NIDCR NIH HHS
  grantid: R01 DE017570-03
GroupedDBID -
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
GX1
H13
IH2
K-O
K78
KQ8
L7B
MVM
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
WH7
WOQ
X
X7M
XJT
ZA5
ZE2
ZGI
---
-~X
.55
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c371t-48408a73edf9350de782d099975fed87e8aa209d3d84d7d0bd60e33e7bed675f3
ISSN 0022-1767
IngestDate Sun Sep 29 07:30:43 EDT 2024
Thu Sep 26 17:18:51 EDT 2024
Sat Sep 28 07:55:26 EDT 2024
Tue Nov 10 19:20:43 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c371t-48408a73edf9350de782d099975fed87e8aa209d3d84d7d0bd60e33e7bed675f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/183/2/1065/1282823/zim01409001065.pdf
PMID 19553521
PQID 67457735
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_67457735
crossref_primary_10_4049_jimmunol_0804354
pubmed_primary_19553521
highwire_smallpub1_www183_2_1065
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20090715
2009-Jul-15
2009-07-15
PublicationDateYYYYMMDD 2009-07-15
PublicationDate_xml – month: 07
  year: 2009
  text: 20090715
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2009
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 8806074 - J Cell Biochem. 1996 Jun 15;61(4):514-23
16203996 - Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14735-40
15845457 - J Immunol. 2005 May 1;174(9):5444-55
17521882 - J Autoimmun. 2007 Aug;29(1):10-9
14657216 - J Exp Med. 2003 Dec 1;198(11):1627-9
9425167 - J Cell Biol. 1998 Jan 12;140(1):197-210
11412301 - Immunology. 2001 Jun;103(2):146-54
16621991 - J Immunol. 2006 May 1;176(9):5255-66
11714760 - J Exp Med. 2001 Nov 19;194(10):1541-7
18806780 - Nature. 2008 Oct 23;455(7216):1109-13
7745114 - J Clin Pathol. 1995 Feb;48(2):143-6
16034110 - J Immunol. 2005 Aug 1;175(3):1694-705
16034141 - J Immunol. 2005 Aug 1;175(3):1965-73
12612578 - Nat Immunol. 2003 Apr;4(4):330-6
12612581 - Nat Immunol. 2003 Apr;4(4):337-42
11138001 - Nat Genet. 2001 Jan;27(1):68-73
16216890 - J Exp Med. 2005 Oct 17;202(8):1063-73
11137992 - Nat Genet. 2001 Jan;27(1):18-20
15753206 - J Exp Med. 2005 Mar 7;201(5):723-35
11907071 - J Immunol. 2002 Apr 1;168(7):3188-94
15036231 - Semin Immunol. 2004 Apr;16(2):81-8
1542691 - Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1924-8
9620682 - Immunity. 1998 May;8(5):615-23
12161590 - J Med Genet. 2002 Aug;39(8):537-45
16720616 - Int Immunol. 2006 Jul;18(7):991-1000
3498635 - Eur J Immunol. 1987 Sep;17(9):1279-85
7907296 - Eur J Immunol. 1994 Mar;24(3):635-40
14525977 - J Biol Chem. 2003 Dec 26;278(52):52730-8
17952042 - Nat Immunol. 2007 Nov;8(11):1173-8
9389301 - J Allergy Clin Immunol. 1997 Nov;100(5):694-701
10528215 - J Immunol. 1999 Nov 1;163(9):5086-93
8402910 - Cell. 1993 Oct 22;75(2):253-61
9636694 - Cell Immunol. 1998 May 1;185(2):158-63
16209918 - Curr Opin Immunol. 2005 Dec;17(6):638-42
18056343 - J Immunol. 2007 Dec 15;179(12):8035-41
11163198 - Immunity. 2000 Dec;13(6):829-40
16216886 - J Exp Med. 2005 Oct 17;202(8):1051-61
2242756 - Eur J Immunol. 1990 Oct;20(10):2201-7
15128778 - J Immunol. 2004 May 15;172(10):5967-72
12242333 - Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13031-6
7525307 - Eur J Immunol. 1994 Nov;24(11):2832-41
7969453 - Nature. 1994 Nov 10;372(6502):190-3
7705417 - Eur J Immunol. 1995 Mar;25(3):852-6
3042615 - Immunol Lett. 1988 Jun;18(2):149-54
12522256 - Science. 2003 Feb 14;299(5609):1057-61
10330442 - J Exp Med. 1999 May 17;189(10):1631-8
2023010203060375000_R6
2023010203060375000_R5
2023010203060375000_R4
2023010203060375000_R3
2023010203060375000_R2
2023010203060375000_R1
2023010203060375000_R17
2023010203060375000_R39
2023010203060375000_R16
2023010203060375000_R38
2023010203060375000_R19
2023010203060375000_R18
2023010203060375000_R13
2023010203060375000_R35
2023010203060375000_R12
2023010203060375000_R34
2023010203060375000_R15
2023010203060375000_R37
2023010203060375000_R14
2023010203060375000_R36
2023010203060375000_R31
2023010203060375000_R30
2023010203060375000_R11
2023010203060375000_R33
2023010203060375000_R10
2023010203060375000_R32
2023010203060375000_R28
2023010203060375000_R27
2023010203060375000_R29
2023010203060375000_R24
2023010203060375000_R46
2023010203060375000_R23
2023010203060375000_R45
2023010203060375000_R26
2023010203060375000_R25
2023010203060375000_R20
2023010203060375000_R42
2023010203060375000_R41
2023010203060375000_R22
2023010203060375000_R44
2023010203060375000_R21
2023010203060375000_R43
2023010203060375000_R9
2023010203060375000_R8
2023010203060375000_R40
2023010203060375000_R7
References_xml – ident: 2023010203060375000_R6
  doi: 10.4049/jimmunol.168.7.3188
– ident: 2023010203060375000_R43
  doi: 10.1038/ni1526
– ident: 2023010203060375000_R14
  doi: 10.1038/83707
– ident: 2023010203060375000_R10
  doi: 10.1126/science.1079490
– ident: 2023010203060375000_R35
  doi: 10.1002/eji.1830201008
– ident: 2023010203060375000_R40
  doi: 10.4049/jimmunol.174.9.5444
– ident: 2023010203060375000_R24
  doi: 10.1136/jcp.48.2.143
– ident: 2023010203060375000_R9
  doi: 10.4049/jimmunol.176.9.5255
– ident: 2023010203060375000_R38
  doi: 10.4049/jimmunol.175.3.1694
– ident: 2023010203060375000_R3
  doi: 10.1016/j.smim.2003.12.003
– ident: 2023010203060375000_R46
  doi: 10.1016/S0091-6749(97)70175-1
– ident: 2023010203060375000_R36
  doi: 10.1073/pnas.89.5.1924
– ident: 2023010203060375000_R8
  doi: 10.1084/jem.20041982
– ident: 2023010203060375000_R7
  doi: 10.1084/jem.20031803
– ident: 2023010203060375000_R28
  doi: 10.1083/jcb.140.1.197
– ident: 2023010203060375000_R18
  doi: 10.1016/S1074-7613(00)80566-X
– ident: 2023010203060375000_R23
  doi: 10.1038/372190a0
– ident: 2023010203060375000_R33
  doi: 10.1084/jem.20051100
– ident: 2023010203060375000_R26
  doi: 10.1002/eji.1830250333
– ident: 2023010203060375000_R1
  doi: 10.1093/intimm/dxl044
– ident: 2023010203060375000_R19
  doi: 10.1006/cimm.1998.1282
– ident: 2023010203060375000_R22
  doi: 10.4049/jimmunol.179.12.8035
– ident: 2023010203060375000_R45
  doi: 10.1084/jem.194.10.1541
– ident: 2023010203060375000_R21
  doi: 10.4049/jimmunol.175.3.1965
– ident: 2023010203060375000_R17
  doi: 10.1016/0092-8674(93)80067-O
– ident: 2023010203060375000_R15
  doi: 10.1136/jmg.39.8.537
– ident: 2023010203060375000_R4
  doi: 10.4049/jimmunol.172.10.5967
– ident: 2023010203060375000_R34
  doi: 10.1002/eji.1830240322
– ident: 2023010203060375000_R11
  doi: 10.1038/ni909
– ident: 2023010203060375000_R12
  doi: 10.1038/ni904
– ident: 2023010203060375000_R13
  doi: 10.1038/83784
– ident: 2023010203060375000_R31
  doi: 10.1016/0165-2478(88)90056-9
– ident: 2023010203060375000_R37
  doi: 10.1046/j.1365-2567.2001.01232.x
– ident: 2023010203060375000_R32
  doi: 10.1073/pnas.192162899
– ident: 2023010203060375000_R39
  doi: 10.1016/j.jaut.2007.04.001
– ident: 2023010203060375000_R44
  doi: 10.1038/nature07336
– ident: 2023010203060375000_R41
  doi: 10.1084/jem.20040662
– ident: 2023010203060375000_R5
  doi: 10.1016/S1074-7613(00)00080-7
– ident: 2023010203060375000_R30
  doi: 10.1002/eji.1830170910
– ident: 2023010203060375000_R16
  doi: 10.1073/pnas.0507014102
– ident: 2023010203060375000_R25
  doi: 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R
– ident: 2023010203060375000_R20
  doi: 10.1074/jbc.M308707200
– ident: 2023010203060375000_R42
  doi: 10.4049/jimmunol.163.9.5086
– ident: 2023010203060375000_R2
  doi: 10.1016/j.coi.2005.09.002
– ident: 2023010203060375000_R27
  doi: 10.1084/jem.189.10.1631
– ident: 2023010203060375000_R29
  doi: 10.1002/eji.1830241138
SSID ssj0006024
Score 2.1013396
Snippet Scurfy (Sf) mice lack CD4(+)Foxp3(+) regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4(+) T cells. Introducing Il2(-/-) gene...
Abstract Scurfy (Sf) mice lack CD4+Foxp3+ regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4+ T cells. Introducing Il2−/− gene...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 1065
SubjectTerms Animals
Antigens, CD - genetics
Antigens, CD - physiology
Cause of Death
CD4-Positive T-Lymphocytes - metabolism
CD4-Positive T-Lymphocytes - transplantation
Inflammation - etiology
Inflammation - mortality
Integrin alpha Chains - genetics
Integrin alpha Chains - physiology
Interleukin-2 - deficiency
Interleukin-2 - physiology
Longevity
Lung - pathology
Mice
Mice, Inbred Strains
Mice, Mutant Strains
Skin - pathology
T-Lymphocytes, Regulatory
Transcriptional Activation
Title IL-2 Regulates CD103 Expression on CD4+ T Cells in Scurfy Mice that Display Both CD103-Dependent and Independent Inflammation
URI http://www.jimmunol.org/cgi/content/abstract/183/2/1065
https://www.ncbi.nlm.nih.gov/pubmed/19553521
https://search.proquest.com/docview/67457735
Volume 183
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIhAXBMurPH1gDyhKN4mTODmyLWi7Yrm0K5VT5NTOsihNq22qqkj8YP4FM3bSpNUiHlKVtlHluP6-jGfib8aEvHVS6TmBk9mhYNz2eSTgluK-LYIojONAZa7eOuH8c3h64Z9Ngkmn87OlWlqVaW_6_ca8kv9BFc4Brpgl-w_IbhuFE_AZ8IUjIAzHv8J4-Mn2YID0bvJqafUHrsOweLHRtha4ENAf-EfeiTW2-irPtfZ1NF1dZxvUyyvwOkWJBTgXudhYJ3PMR8I27EG1NW5ZyYXl9vuwyIBDswbPbw3dWs7tFaadmPJOR3oRzWk9chjpctkaXPG1ESaOKrsD7_ZSFJfQXsPHVGxEUwwBrdI2heJsZZSZlyoXKC0Rc_tLPSHXzzMwhco2GZ1VCoEhpjWczYp53rbdEDa73Gze0VOVuQ4g-A2dcNeesxZxvZZ1hvA3uGna8CFMwmmjGpseeNHgRfrtnwLwi5mmEQwZlsRxmwm0Fg3szatbteN6vYY-JV6C179FbnscmsC89EmjRgodz68L2-OfNCvq2LHj_W7pOremD7vOVF3g-vfBknaaxg_I_YoQ9L2h7kPSUcUhuWP2P90ckrvnlbLjEfmBXKZbLlPNQ9pwmcILuGzRMdVMplcFNUymyGSKTKYVkykyme4xmQKTaYvJtM3kx-Ti44dx_9Sutgaxp4y7pe1HvhMJzpTMYhY4UoGjKzHY4UGmZMRVJITnxJLJyJdcgkUKHcWY4qmSECJn7Ak5KOaFekZoGIo4nUpXcCx1yZxYuNMQDBWYtpgz6XfJu3qMk4WpAANAJghNUkOTVNB0Ca1BSJYzkecw-G6yg3-XvKnBScCS4_KcKNR8tUxC7gecM_jFU4NZc7kK7ud_bv4FudfcVC_JQXm9Uq_AbS7T15pwvwAb4bxS
link.rule.ids 315,786,790,27955,27956
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-2+Regulates+CD103+Expression+on+CD4%2B+T+Cells+in+Scurfy+Mice+that+Display+Both+CD103-Dependent+and+Independent+Inflammation&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Sharma%2C+Rahul&rft.au=Sung%2C+Sun-sang+Joe&rft.au=Abaya%2C+Christian+E&rft.au=Ju%2C+Angela+Chiao-Ying&rft.date=2009-07-15&rft.pub=Am+Assoc+Immnol&rft.issn=0022-1767&rft.eissn=1550-6606&rft.volume=183&rft.issue=2&rft.spage=1065&rft_id=info:doi/10.4049%2Fjimmunol.0804354&rft_id=info%3Apmid%2F19553521&rft.externalDBID=n%2Fa&rft.externalDocID=www183_2_1065
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon